Magrolimab (CD47) - Onderzoeksgrade Biosimilar
Gecertificeerd

Magrolimab (CD47) - Onderzoeksgrade Biosimilar

Catalog #: 10-950
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Magrolimab is anti-CD47 monoclonal antibody designed to promote phagocytosis of cancer cells by macrophages. Its purpose is to interfere with the recognition of CD47 by SIRPα receptors on macrophages, thereby blocking the self-protection signals used by cancer cells to avoid being swallowed by macrophages.

Immunogen

Chimeric, Humanized / CD47 [Homo sapiens]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Cancer

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

IgG4-kappa

NCBI Organism

Homo sapiens

Other Product Names

Hu5F9-G4

Beschrijving

Magrolimab (CD47) - Onderzoeksgrade Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamMagrolimab (CD47) - Onderzoeksgrade Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer10-950